119 related articles for article (PubMed ID: 557057)
1. Analysis by high-pressure liquid chromatography of 9-beta-D-arabinofuranosyladenine 5'-triphosphate levels in murine leukemia cells.
Rose LM; Brockman RW
J Chromatogr; 1977 Mar; 133(2):335-43. PubMed ID: 557057
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of 9-beta-d-arabinofuranosyladenine cytotoxicity to mouse leukemia L1210 in vitro by 2'-deoxycoformycin.
Cass CE; Au-Yeung TH
Cancer Res; 1976 Apr; 36(4):1486-91. PubMed ID: 944095
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of the 5'-triphosphates of 9-beta-(2'-azido-2'-deoxy-D-arabinofuranosyl)adenine and 9-beta-D-arabinofuranosyladenine on DNA polymerases from L1210 leukemia cells.
Allaudeen HS; Kozarich JW; Sartorelli AC
Nucleic Acids Res; 1982 Feb; 10(4):1379-87. PubMed ID: 6175955
[TBL] [Abstract][Full Text] [Related]
4. Modulation of 9-beta-D-arabinofuranosyladenine 5'-triphosphate and deoxyadenosine triphosphate in leukemic cells by 2'-deoxycoformycin during therapy with 9-beta-D-arabinofuranosyladenine.
Plunkett W; Benjamin RS; Keating MJ; Freireich EJ
Cancer Res; 1982 May; 42(5):2092-6. PubMed ID: 6175407
[TBL] [Abstract][Full Text] [Related]
5. Relationship between incorporation of 9-beta-D-arabinofuranosyladenine in L 1210 DNA and cytotoxicity.
Kufe DW; Major PP; Munroe D; Egan M; Herrick D
Cancer Res; 1983 May; 43(5):2000-4. PubMed ID: 6831429
[TBL] [Abstract][Full Text] [Related]
6. Antiproliferative effects of 9-beta-D-arabinofuranosyladenine 5'-monophosphate and related compounds in combination with adenosine deaminase inhibitors against mouse leukemia L1210/C2 cells in culture.
Cass CE; Tan TH; Selner M
Cancer Res; 1979 May; 39(5):1563-9. PubMed ID: 85484
[TBL] [Abstract][Full Text] [Related]
7. Penetration of mouse fibroblasts by the 5'-phosphate of 9-beta-D-arabinofuranosyladenine and incorporation of the nucleotide into DNA.
Plunkett W; Lapi L; Ortiz PJ; Cohen SS
Proc Natl Acad Sci U S A; 1974 Jan; 71(1):73-7. PubMed ID: 4359332
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the actions of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine on target enzymes from mouse tumor cells.
White EL; Shaddix SC; Brockman RW; Bennett LL
Cancer Res; 1982 Jun; 42(6):2260-4. PubMed ID: 7042080
[TBL] [Abstract][Full Text] [Related]
9. 2-fluoro-ATP: a toxic metabolite of 9-beta-D-arabinosyl-2-fluoroadenine.
Avramis VI; Plunkett W
Biochem Biophys Res Commun; 1983 May; 113(1):35-43. PubMed ID: 6860342
[TBL] [Abstract][Full Text] [Related]
10. Effect of 9-beta-D-arabinofuranosyladenine on DNA synthesis in vivo.
Müller WE; Maidhof A; Zahn RK; Shannon WM
Cancer Res; 1977 Jul; 37(7 Pt 1):2282-90. PubMed ID: 301056
[No Abstract] [Full Text] [Related]
11. The mechanisms of lethal action of arabinosyl cytosine (araC) and arabinosyl adenine (araA).
Cohen SS
Cancer; 1977 Jul; 40(1 Suppl):509-18. PubMed ID: 328134
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of the antitumor activity of arabinofuranosyladenine of 2'-deoxycoformycin.
LePage GA; Worth LS; Kimball AP
Cancer Res; 1976 Apr; 36(4):1481-5. PubMed ID: 946595
[TBL] [Abstract][Full Text] [Related]
13. Metabolism and chemotherapeutic activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia L1210 and evidence for its phosphorylation by deoxycytidine kinase.
Brockman RW; Cheng YC; Schabel FM; Montgomery JA
Cancer Res; 1980 Oct; 40(10):3610-5. PubMed ID: 6254636
[TBL] [Abstract][Full Text] [Related]
14. The utilization of nucleotides by animal cells.
Cohen SS; Plunkett W
Ann N Y Acad Sci; 1975 Aug; 255():269-86. PubMed ID: 1059361
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of 9-beta-D-arabinofuranosyladenine and 2'-deoxycoformycin combinations on intracerebral leukemia.
Lee SH; Caron N; Kimball AP
Cancer Res; 1977 Jul; 37(7 Pt 1):1953-5. PubMed ID: 861931
[TBL] [Abstract][Full Text] [Related]
16. Pharmacodynamics and proposed mechanism of therapeutic action and host toxicity of 9-beta-D-arabinofuranosyl-2-fluoroadenine monophosphate (F-araAMP) in P388 murine leukemia-bearing mice.
Avramis VI
Cancer Invest; 1989; 7(2):129-37. PubMed ID: 2477118
[TBL] [Abstract][Full Text] [Related]
17. Effects of 2'-deoxycoformycin, 9-beta-D-arabinofuranosyladenine 5'-phosphate, and 1-beta-D-arabinofuranosylcytosine triple combination therapy on intracerebral leukemia 1210.
Caron N; Lee SH; Kimball AP
Cancer Res; 1977 Sep; 37(9):3274-9. PubMed ID: 884674
[TBL] [Abstract][Full Text] [Related]
18. Interaction of 9-beta-D-arabinofuranosyladenine, 9-beta-D-arabinofuranosyladenine 5'-monophosphate, and 9-beta-D-arabinofuranosyladenine 5'-triphosphate with S-adenosylhomocysteinase.
Helland S; Ueland PM
Cancer Res; 1981 Feb; 41(2):673-8. PubMed ID: 6160909
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneous uptake of 9-beta-D-arabinofuranosyladenine by mouse spleen lymphocytes.
Almeida AF
Can J Physiol Pharmacol; 1985 Sep; 63(9):1175-81. PubMed ID: 4052876
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of DNA synthesis in permeabilized mouse P815 mast cells by arabinofuranosyladenine 5'-triphosphate.
Geurtsen W; Zahn RK; Maidhof A; Schmidseder R; Müller WE
Chemotherapy; 1981; 27(1):61-7. PubMed ID: 6163594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
